Solid Biosciences Inc (SLDB)
10.43
+0.46
(+4.61%)
USD |
NASDAQ |
May 07, 16:00
10.43
0.00 (0.00%)
After-Hours: 16:44
Solid Biosciences Cash and Short Term Investments (Quarterly): 123.64M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 123.64M |
| September 30, 2023 | 142.88M |
| June 30, 2023 | 160.19M |
| March 31, 2023 | 185.51M |
| December 31, 2022 | 213.72M |
| September 30, 2022 | 142.16M |
| June 30, 2022 | 162.88M |
| March 31, 2022 | 180.05M |
| December 31, 2021 | 207.78M |
| September 30, 2021 | 229.76M |
| June 30, 2021 | 248.96M |
| March 31, 2021 | 268.50M |
| December 31, 2020 | 154.74M |
| September 30, 2020 | 24.80M |
| Date | Value |
|---|---|
| June 30, 2020 | 40.44M |
| March 31, 2020 | 53.59M |
| December 31, 2019 | 83.52M |
| September 30, 2019 | 105.66M |
| June 30, 2019 | 67.39M |
| March 31, 2019 | 94.74M |
| December 31, 2018 | 122.46M |
| September 30, 2018 | 145.37M |
| June 30, 2018 | 162.76M |
| March 31, 2018 | 182.38M |
| December 31, 2017 | 69.09M |
| September 30, 2017 | 29.57M |
| December 31, 2016 | 37.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
24.80M
Minimum
Sep 2020
268.50M
Maximum
Mar 2021
147.17M
Average
154.74M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 1.391B |
| PTC Therapeutics Inc | 884.81M |
| Capricor Therapeutics Inc | 39.49M |
| Perspective Therapeutics Inc | 9.238M |
| Electromed Inc | 10.43M |